MÜLLER, B. et al. Severe cutaneous toxicity in a 67-year-old patient with metastatic urothelial carcinoma undergoing therapy with enfortumab vedotin and pembrolizumab. European Journal of Case Reports in Internal Medicine, v. 11, n. 12, 28 Nov.2024.